Previous studies have demonstrated that models of hypertensive CKD and inflammation CKD increase the expression of Cx43 in the early stage of CKD in the glomerulus [49], whereas increased HC activity occurs during heart attack and failure [50,51], neurodegenerative diseases [52], and liver fibrosis [53]. Here, GJA1 is linked to neurodegenerative disease.